Shiitake: A Major Medicinal Mushroom

Alternative and Complementary Therapies

Volumn 4, Issue 1, 1998, Pages 53-59

  Jones, Kenneth ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1242280230     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/act.1998.4.53     Document Type: Article

References (47)

1. Mori, K. Mushrooms as Health Foods. Tokyo: Japan Publications, 1974.
2. Herbs/botanicals. Vitamin Retailer 4(10): 160–161, 1997.
3. Chang, R. Functional properties of edible mushrooms. Nutr Rev 54(part II): S91-S93, 1996.
4. Breene, W. M. Nutritional and medicinal value of specialty mushrooms. J Food Protect 53: 883–894, 1990.
5. Advertisement. Maitake, the king of mushrooms arrives. Let's Live November 1992, p. 26.
6. Jones, K. Shiitake, the Healing Mushroom. Rochester, VT: Healing Arts Press, 1995.
7. Aoki, T., Miyakoshi, H., Usuda, Y., et al. Antibodies to HTLV-I and -III in sera of two Japanese patients, one with possible pre-AIDS. Lancet 325: 936–937, 1984.
8. Johansen, H. N., Wood, J., Knudsen, K. E. B. Molecular weight changes in the (1→3)(1→4)-β-D-glucan of oats incurred by the digestive processes in the upper gastrointestinal tract of pigs. JAgrie Food Chem 41: 2347–2352, 1993.
9. Nishikawa, T., Inagawa, H., Oshima, H., et al. Homeostasis regulated by activated macrophage. I. Lipopolysaccharide (LPS) from wheat flour: Isolation, purification and some biological activities. Chem Pharm Bull 40: 479–483, 1992.
10. Inagawa, H., Nishizawa, T., Noguchi, K., et al. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system. Anticancer Res 17: 2153–2158, 1997.
11. Matsuoka, H., Seo, Y., Wakasugi, H., Saito, T., Tomoda, H. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res 17: 2751–2756, 1997.
12. Gordon, M., Guralnik, M., Kaneko, Y., et al. A phase II controlled study of a combination of the immune modulator, lentinan, with didano-sine (ddl) in HIV patients with CD4 cells of 200–500/mm3. J Med 26: 193–207, 1995.
13. Aoki, T., Usuda, Y. Miyakoshi, H., Tamura, K., Herberman, R. B. Low natural killer syndrome: Clinical and immunological features. Nat Immun Cell Growth Reg 6: 116–128, 1987.
14. Hanaue, H., Tokuda, Y., Machimura, T., et al. Basic studies on oral administration of lentinan I: Influence on lymphocyte subsets in peripheral venous blood. J Jpn Soc Cancer Ther 24: 1566–1571, 1989.
15. Hanaue, H., Tokuda, Y., Machimura, T., et al. Effects of oral lentinan on T-cell subsets in peripheral venous blood. Clin Ther 11: 614–622, 1989.
16. Chihara, G., Hamuro, J., Maeda, Y. Y., Arai, Y., Fukuoka, F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing, (an edible mushroom). Cancer Res 30: 2776–2781, 1970.
17. Mizuno, M., Minato, K. I., Tsuchida, H. Preparation and specificity of antibodies to an anti-tumor β-glucan, lentinan. Biochem Mol Biol Int 39: 679–685, 1996.
18. Hibino, Y., Konishi, Y., Koike, J., Tabata, T., Ohashi, Y., Sugano, N. Productions of interferon-γ and nitrite are induced in mouse splenic cells by a heteroglycan-protein fraction from culture medium of Lentinus edodes mycelia. Immunopharmacology 28: 77–85, 1994.
19. Nanba, H., Mori, K., Toyomasu, T., Kuroda, H. Antitumor action of shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharm Bull 35: 2453–2458, 1987.
20. Mizuno, T. Shiitake, Lentinus edodes: Functional properties for medicinal and food purposes. Food Revint 11:111–128, 1995.
21. Kim, Y. S., Park, K. S., Park, H. K., Kim, S. W. Compositional sugar analysis of antitumor polysaccharides by high performance liquid chromatography and gas chromatography. Arch Pharm Res 17: 337–342, 1994.
22. Nanba, H., Kuroda, H. Antitumor mechanisms of orally administered shiitake fruit bodies. Chem Pharm Bull 35: 2459–2464, 1987.
23. Amagase, H. Treatment of hepatitis B patients with Lentinus edodes mycelium. Reprinted in: New Trends in Peptic Ulcer and Chronic Hepatitis—Part II: Chronic Hepatitis. Excerpta Med, 1987, pp. 316–321.
24. Harada, T., Kanetaka, T., Suzuki, H., Suzuki, K. Therapeutic effect of LEM (extract of cultured Lentinus edodes mycelia) against HBeAg-positive chronic hepatitis B (abstr. 719). Gastroenterol Int 1(Suppl. 1), 1988.
25. Shirahata, A., Mori, K., Kishida, K., et al. Immunological effect of LEM (the extract of cultured Lentinus edodes mycelia) in HIV infected hemophiliacs (abstr. 145). In: XIX International Congress of the World Federation of Hemophilia, Washington, D. C., August 14–19, 1990. 1990, pp. 35–37.
26. Sugano, N., Hibino, Y., Choji, Y., Maeda, H. Anticarcinogenic actions of water-soluble and alcohol-insoluble fractions from culture medium of Lentinus edodes mycelia. Cancer Lett 17: 109–114, 1982.
27. Morinaga, H., Tazawa, K., Tagoh, H., Muraguchi, A., Fujimaki, M. An in vivo study of hepatic and splenic interferon-lβ mRNA expression following oral PSK or LEM administration. Jpn 1 Cancer Res 85: 1298–1303, 1994.
28. Wong, G. Y. C., Katdare, M., Osborne, M. P., Telang, N. T. Preventive efficacy of Lentinus edodes mycelium extract (LEM) in human mammary carcinogenesis (abstr. 321). In: 19th Annual San Antonio Breast Cancer Symposium, [San Antonio, Texas] December 11–14, 1996, Program and Abstracts. 1996, p. 265.
29. Tochikura, T. S., Nakashima, H., Ohashi, Y., Yamamoto, N. Inhibition of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med Microbiol Immunol 177: 235–244, 1988.
30. Suzuki, H., Okubo, A., Yamazaki, S., Suzuki, K., Mitsuya, H., Toda, S. Inhibition of the infectivity and cytopathic effect of human immunodeficiency virus by water-soluble lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM). Biochem Biophys Res Commun 160: 367–373, 1989.
31. Suzuki, H., Iiyama, K., Yoashida, O., Yamazaki, S., Yamamoto, N., Toda, S. Structural characterization of the immunoactive and antiviral water-solubilized lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM). Agrie Biol Chem 54: 479–487, 1990.
32. Sorimachi, K., Niwa, A., Yamazaki, S., Toda, S. Antiviral activity of water-solubilized lignin derivatives in vitro. Agrie Biol Chem 54: 1337–1339, 1990.
33. Iizuka, C. Antivirus substance and process for producing same. Eur Pat Appl (Application Number 0 464 311 A2), March 20, 1991.
34. Lin, S. Y. Lignin. In: Gerhartz, W., Yamamoto, Y. S., Campbell, F. T., Pfefferkorn, R., Rounsaville, J. F. (eds.), Ullman's Encyclopedia of Industrial Chemistry, 5th ed., Series A, Volume 15. Weinheim, Germany: VCH Verlagsge-sellschaft m.b.H., 1990, pp. 305–315.
35. Fujii, T., Maeda, H., Suzuki, F., Ishida, N. Isolation and characterization of a new antitumor polysaccharide, KS-2, extracted from culture mycelia of Lentinus edodes. J Antibiot 31: 1079–1090, 1978.
36. Suzuki, F., Suzuki, C., Shimomura, E., Maeda, H., Fujii, T., Ishida, N. Antiviral and interferon-inducing activities of a new peptidomannan, KS-2, extracted from culture mycelia of Lentinus edodes. J Antibiot 32: 1336–1345, 1979.
37. Yamashita, A., Ohtsuka, H., Maeda, H. Intestinal absorption and urinary excretion of antitumor peptidomannan KS-2 after oral administration in rats. Immunopharmacology 5: 209–220, 1983.
38. Suzuki, S., Ohshima, S. Influence of shii-ta-ke (Lentinus edodes) on human serum cholesterol. In: Mori, K., Ch'iu, J. C. (eds.), Proceedings of the Ninth International Scientific Congress on the Cultivation of Edible Fungi, Tokyo, November 4–10, 1974. In: Mushroom Science IX, Part1. Kiryu, Japan: Mushroom Research Institute, 1976, pp. 463–467.
39. Hokama, Y., Hokama, J. L. R. Y. In vitro inhibition of platelet aggregation with low dalton compounds from aqueous dialysates from edible fungi. Res Commun Chem Pathol Pharmacol 31: 177–180, 1981.
40. Sugiyama, K., Yamakawa, A. Dietary eritadenine-induced alteration of molecular species composition of phospholipid in rats. Lipids 31: 399–404, 1996.
41. Kaneda, T., Tokuda, S. Effect of various mushroom preparations on cholesterol levels in rats. J Nutr 90: 371–376, 1966.
42. Tokuda, S., Kaneda, T. Effect of shii-ta-ke mushroom on plasma cholesterol levels in rats. In: Delmas, J. (ed.), Proceedings of the Tenth International Congress on the Science and Cultivation of Edible Fungi, Bordeaux, France, June 5–6, 1978. In: Mushroom Science X, Part 2. Point de la Maye, France: L'Institut National de la Recherche Agronomique, 1979, pp. 793–796.
43. Tokuda, S., Tagiri, A., Kano, E., et al. Reducing mechanism of plasma cholesterol by shii-ta-ke. In: Mori, K., Ch'iu, J. C. (eds.), Proceedings of the Ninth International Scientific Congress on the Cultivation of Edible Fungi, Tokyo, November 4–10, 1974. In: Mushroom Science IX, Part 1. Kiryu, Japan: Mushroom Research Institute, 1976, pp. 445–462.
44. Sugiyama, K., Akaschi, T., Tomakawa, A. Hypocholesterolemic action of eritadenine is mediated by a modification of hepatic phospholipid metabolism in rats. J Nutr 125: 2134–2144, 1995.
45. Kurasawa, S. I., Sugahara, T., Hayashi, J. Studies on dietary fibre of mushrooms and edible wild plants. Nutr Rep Int 26: 167–173, 1982.
46. Sannoumaru, Y., Shimizu, J., Nakamura, K., Hayakawa, T., Takita, T., Innami, S. Effects of semi-purified dietary fibers from Lagenaria siceraria, Raphanus sativas and Lentinus edodes on fecal steroid excretion in rats. J Nutr Sci Vitaminol (Tokyo) 42: 97–110, 1996.
47. Lien, E. J., Das, A., Lien, L. L. Immunophar-macological and biochemical bases of Chinese herbal medicine. Prog Drug Res 46: 263–280, 1996.